Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07845500 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

Name: A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity — clinical trial record (NCT07845500)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorPfizer

Started2026-10-01

View on ClinicalTrials.gov ↗

Pfizer

431 trials monitored

See 32 trials at risk

Obesity

3,523 trials monitored

See 133 trials at risk

The purpose of this study is to learn about the safety and effectiveness of berobenatide in adults with overweight or obesity who have already lost weight while taking semaglutide or tirzepatide. The study does not include people with diabetes. Participants will be in the study for about 11 months.

Trial Details

NCT Number	NCT07845500
Lead Sponsor	Pfizer
Conditions	Obesity, Overweight and/or Obesity, Overweight, Treatment Of Obesity
Enrollment	660 participants
Start Date	2026-10-01
Primary Completion	2028-02-16 (estimated)
Study Completion	2028-02-16 (estimated)
Updated on ClinicalTrials.gov	2026-09-29